1. Home
  2. INTS
  3. INTS News

Latest Intensity Therapeutics Inc. Common stock (INTS) News on July 27, 2024

Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase 3 Study (INVINCIBLE-3) in Metastatic Soft Tissue Sarcoma

PR Newswire

18 days ago

Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase 3 Study (INVINCIBLE-3) in Metastatic Soft Tissue Sarcoma

Thomson Reuters StreetEvents

9 months ago

Q3 2023 SoundThinking Inc Earnings Call

Share on Social Networks: